296
Views
17
CrossRef citations to date
0
Altmetric
Original Research

Identifying and prioritizing concerns associated with prosthetic devices for use in a benefit-risk assessment: a mixed-methods approach

, , &
Pages 385-398 | Received 22 Nov 2017, Accepted 25 Apr 2018, Published online: 08 May 2018

References

  • Ziegler-Graham K, MacKenzie EJ, Ephraim PL, et al. Estimating the prevalence of limb loss in the United States: 2005 to 2050. Arch Phys Med Rehabil. 2008 Mar;89(3):422–429.
  • Beasley RW. General considerations in managing upper limb amputations. Orthop Clin North Am. 1981 Oct;12(4):743–749.
  • Behrend C, Reizner W, Marchessault JA, et al. Update on advances in upper extremity prosthetics. J Hand Surg Am. 2011 Oct;36(10):1711–1717.
  • Center NLLI. Amputation statistics by cause. Limb loss in the United States. NLLIC fact sheet 2008 [cited 2017 Jun 15]. Available from: http://www.amputee-coalition.org/fact_sheets/amp_stats_cause.pdf
  • Adams PF, Hendershot GE, Marano MA, et al. Current estimates from the National Health Interview Survey, 1996. Vital Health Stat. 1999 Oct;10(200):1–203.
  • Krueger CA, Wenke JC, Ficke JR. Ten years at war: comprehensive analysis of amputation trends. J Trauma Acute Care Surg. 2012 Dec;73(6 Suppl 5):S438–444.
  • Resnik L, Meucci MR, Lieberman-Klinger S, et al. Advanced upper limb prosthetic devices: implications for upper limb prosthetic rehabilitation. Arch Phys Med Rehabil. 2012 Apr;93(4):710–717.
  • Fraser CM. An evaluation of the use made of cosmetic and functional prostheses by unilateral upper limb amputees. Prosthet Orthot Int. 1998 Dec;22(3):216–223.
  • Pillet J, Didierjean-Pillet A. Aesthetic hand prosthesis: gadget or therapy? Presentation of a new classification. J Hand Surg Br. 2001 Dec;26(6):523–528.
  • van Lunteren A, van Lunteren-Gerritsen GH, Stassen HG, et al. A field evaluation of arm prostheses for unilateral amputees. Prosthet Orthot Int. 1983 Dec;7(3):141–151.
  • Millstein SG, Heger H, Hunter GA. Prosthetic use in adult upper limb amputees: a comparison of the body powered and electrically powered prostheses. Prosthet Orthot Int. 1986 Apr;10(1):27–34.
  • Datta D, Kingston J, Ronald J. Myoelectric prostheses for below-elbow amputees: the Trent experience. Int Disabil Stud. 1989 Oct-Dec;11(4):167–170.
  • Scotland TR, Galway HR. A long-term review of children with congenital and acquired upper limb deficiency. J Bone Joint Surg Br. 1983 May;65(3):346–349.
  • Cordella F, Ciancio AL, Sacchetti R, et al. Literature review on needs of upper limb prosthesis users. Front Neurosci. 2016;10:209.
  • Sanchez J . Revolutionizing prosthetics: DARPA; [ cited 2017 June 15]. Available from: http://www.darpa.mil/program/revolutionizing-prosthetics
  • Resnik L, Klinger SL, Etter K. The DEKA Arm: its features, functionality, and evolution during the Veterans Affairs Study to optimize the DEKA Arm. Prosthet Orthot Int. 2014 Dec;38(6):492–504..
  • Johannes MS, Bigelow JD, Burck JM, et al. An overview of the developmental process for the modular prosthetic limb. Johns Hopkins APL Tech Dig. 2011;30:207–216.
  • Resnik L, Borgia M, Latlief G, et al. Self-reported and performance-based outcomes using DEKA Arm. J Rehabil Res Dev. 2014;51(3):351–362.
  • Baker JJ, Scheme E, Englehart K, et al. Continuous detection and decoding of dexterous finger flexions with implantable myoelectric sensors. IEEE Trans Neural Syst Rehabil Eng. 2010 Aug;18(4):424–432.
  • Ortiz-Catalan M, Branemark R, Hakansson B, et al. On the viability of implantable electrodes for the natural control of artificial limbs: review and discussion. Biomed Eng Online. 2012;11:33.
  • Jonsson S, Caine-Winterberger K, Branemark R. Osseointegration amputation prostheses on the upper limbs: methods, prosthetics and rehabilitation. Prosthet Orthot Int. 2011 Jun;35(2):190–200.
  • Clark GA, Wendelken S, Page DM, et al. Using multiple high-count electrode arrays in human median and ulnar nerves to restore sensorimotor function after previous transradial amputation of the hand. Conf Proc IEEE Eng Med Biol Soc. 2014;2014:1977–1980.
  • Horch K, Meek S, Taylor TG, et al. Object discrimination with an artificial hand using electrical stimulation of peripheral tactile and proprioceptive pathways with intrafascicular electrodes. IEEE Trans Neural Syst Rehabil Eng. 2011 Oct;19(5):483–489.
  • Raspopovic S, Capogrosso M, Petrini FM, et al. Restoring natural sensory feedback in real-time bidirectional hand prostheses. Sci Transl Med. 2014 Feb 05;6(222):222ra219..
  • Tan DW, Schiefer MA, Keith MW, et al. A neural interface provides long-term stable natural touch perception. Sci Transl Med. 2014 Oct 08;6(257):257ra138..
  • Tillander J, Hagberg K, Hagberg L, et al. Osseointegrated titanium implants for limb prostheses attachments: infectious complications. Clin Orthop Relat Res. 2010 Oct;468(10):2781–2788.
  • Weber D Hand Proprioception and Touch Interfaces (HAPTIX): DARPA; [ cited 2017 June 29]. Available from: http://www.darpa.mil/program/hand-proprioception-and-touch-interfaces
  • Ho M, Saha A, McCleary KK, et al. A framework for incorporating patient preferences regarding benefits and risks into regulatory assessment of medical technologies. Value Health. 2016 Sep - Oct;19(6):746–750.
  • Ho MP, Gonzalez JM, Lerner HP, et al. Incorporating patient-preference evidence into regulatory decision making. Surg Endosc. 2015;29(10):2984–2993.
  • United States Food and Drug Administration (FDA). Patient Preference Information – Voluntary Submission, Review in Premarket Approval Applications, Humanitarian Device Exemption Applications, and De Novo Requests, and Inclusion in Decision Summaries and Device Labeling 2016 [cited 2017 Aug 23]. Available from: http://www.fda.gov/downloads/medicaldevices/deviceregulationandguidance/guidancedocuments/ucm446680.pdf
  • United States Food and Drug Administration (FDA). Factors to consider when making benefit-risk determinations in medical device premarket approval and de novo classification. FDA Guidance for Industry and Food and Drug Administration Staff Silver Spring, Maryland: Center for Device and Radiological Health. Center for Biologics Evaluation and Research; 2012 [cited 2017 Nov 1]. Available from: https://www.fda.gov/downloads/medicaldevices/deviceregulationandguidance/guidancedocuments/ucm517504.pdf.
  • United States Food and Drug Administration (FDA). Factors to Consider When Making Benefit-Risk Determinations for Medical Device Investigational Device Exemptions 2017 [cited 2017 Nov 1]. Available from: https://www.fda.gov/downloads/MedicalDevices/DeviceRegulationandGuidance/GuidanceDocuments/UCM451440.pdf
  • Bridges JF, Hauber AB, Marshall D, et al. Conjoint analysis applications in health–a checklist: a report of the ISPOR Good Research Practices for Conjoint Analysis Task Force. Value Health. 2011 Jun;14(4):403–413.
  • Janssen EM, Segal JB, Bridges JFA. Framework for instrument development of a choice experiment: an application to type 2 diabetes. Patient. 2016 Oct;9(5):465–479.
  • Coast J, Al-Janabi H, Sutton EJ, et al. Using qualitative methods for attribute development for discrete choice experiments: issues and recommendations. Health Econ. 2012;21(6):730–741.
  • Johnson FR, Lancsar E, Marshall D, et al. Constructing experimental designs for discrete-choice experiments: report of the ISPOR Conjoint Analysis Experimental Design Good Research Practices Task Force. Value Health. 2013;16(1):3–13.
  • Hauber AB, Gonzalez JM, Groothuis-Oudshoorn CG, et al. Statistical methods for the analysis of discrete choice experiments: a report of the ISPOR Conjoint Analysis Good Research Practices Task Force. Value Health. 2016 Jun;19(4):300–315.
  • Flynn TN, Louviere JJ, Peters TJ, et al. Best-worst scaling: what it can do for health care research and how to do it. J Health Econ. 2007;26. doi: 10.1016/j.jhealeco.2006.04.002.
  • Peay HL, Hollin I, Fischer R, et al. A community-engaged approach to quantifying caregiver preferences for the benefits and risks of emerging therapies for Duchenne muscular dystrophy. Clin Ther. 2014 May 01;36(5):624–637.
  • Hollin IL, Caroline Y, Hanson C, et al. Developing a patient-centered benefit-risk survey: a community-engaged process. Value Health. 2016 Sep - Oct;19(6):751–757.
  • Benz HL, Yao J, Rose L, et al. Upper extremity prosthesis user perspectives on unmet needs and innovative technology. 2016 38th Annu Int Conf IEEE Eng Med Biol Soc (EMBC. 2016;16–20(Aug):2016.
  • United States Food and Drug Administration (FDA). Public Workshop - CDRH Veteran Amputee Device Workshop, October 31, 2016 2016 [cited 2017 Nov 1]. Available from: https://www.fda.gov/MedicalDevices/NewsEvents/WorkshopsConferences/ucm523312.htm
  • Flynn TN. Valuing citizen and patient preferences in health: recent developments in three types of best-worst scaling. Expert Rev of Pharmacoeconomics and Outcomes Res. 2010 June;10(3):259–267.
  • McFadden D. Conditional logit analysis of qualitative choice behavior. In: Zarembka P, editor. Frontiers in econometrics. New York: Academic Press; 1974. p. 105–142.
  • Louviere JJ, Islam T. Comparison of importance weights and willingness-to-pay measures derived from choice-based conjoint, constant sum scales and best-worst scaling. J Bus Res. 2008 Sep;61(9):903–911.
  • Flynn TN, Louviere JJ, Peters TJ, et al. Best-worst scaling: what it can do for health care research and how to do it. J Health Econ. 2007 January;26(1):171–189.
  • Erdem S, Rigby D. Investigating heterogeneity in the characterization of risks using best worst scaling. Risk Anal. 2013 September;33(9):1728–1748.
  • Ross M, Bridges JFP, Ng X, et al. A best-worst scaling experiment to prioritize caregiver concerns about attention-deficit/hyperactivity disorder (ADHD) medication for children. Psychiatr Serv. 2015 Feb 1;66(2):208–211.
  • Marley AAJ, Louviere JJ. Some probabilistic models of best, worst, and best-worst choices. J Math Psychol. 2005;49. doi: 10.1016/j.jmp.2005.05.003
  • Flynn TN, Louviere JJ, Peters TJ, et al. Estimating preferences for a dermatology consultation using best-worst scaling: comparison of various methods of analysis. BMC Med Res Methodol. 2008;8:76.
  • Bech M, Gyrd-Hansen D. Effects coding in discrete choice experiments. Health Econ. 2005 Oct;14(10):1079–1083.
  • Sawtooth Software. The MaxDiff System Technical Paper 2013 [ cited2018 April 29]. Available from: https://www.sawtoothsoftware.com/download/techpap/maxdifftech.pdf
  • Ritchie S, Wiggins S, Sanford A. Perceptions of cosmesis and function in adults with upper limb prostheses: a systematic literature review. Prosthet Orthot Int. 2011;35(4):332–341.
  • Biddiss EA, Chau TT. Upper limb prosthesis use and abandonment: a survey of the last 25 years. Prosthet Orthot Int. 2007 Sep;31(3):236–257.
  • Peay HL, Hollin IL, Bridges JFP. Prioritizing parental worry associated with Duchenne muscular dystrophy using best-worst scaling [journal article]. J Genet Couns. 2016;25(2):305–313.
  • Lagerkvist CJ, Okello J, Karanja N. Anchored vs. relative best–worst scaling and latent class vs. hierarchical Bayesian analysis of best–worst choice data: investigating the importance of food quality attributes in a developing country. Food Qual Prefer. 2012;25(1):29–40. [2012 Jul 01].
  • Ryan M. Using consumer preferences in health care decision making. The application of conjoint analysis. London: Office of Health Economics; 1996.
  • Cheung KL, Wijnen BFM, Hollin IL, et al. Using best–worst scaling to investigate preferences in health care. PharmacoEconomics. 2016;34(12):1195–1209.
  • Clark MD, Determann D, Petrou S, et al. Discrete choice experiments in health economics: a review of the literature. Pharmacoeconomics. 2014 Sep;32(9):883–902.
  • Flynn TN, Louviere JJ, Marley AA, et al. Rescaling quality of life values from discrete choice experiments for use as QALYs: a cautionary tale. Popul Health Metr. 2008;6(1):6.
  • Janssen EM, Hauber AB, Bridges JFP. Conducting a discrete choice experiment study following recommendations for good research practices: an application for eliciting patient preferences for diabetes treatments. Value in Health. 2017;21(1):59–68.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.